Translational Study of Molecular Classification of Relapsed/Refractory Diffuse Large B-cell Lymphoma

Clinical trial NCT05318391 · COMPLETED

Trial details

NCT number: NCT05318391
Sponsor: Shanghai Zhongshan Hospital
Status: COMPLETED
Study type: OBSERVATIONAL

Lymphoma, Large B-Cell, Diffuse Gene Expression Profiling

Start date: 2021-04-14
Primary completion: 2022-01-30
Enrollment: 324

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.